EXCLUSIVE-WHO SET TO APPROVE ASTRAZENECA COVID-19 VACCINE MANUFACTURED BY SK BIOSCIENCE IN SOUTH KOREA FROM END OF FEB - DOCUMENT
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,100 GBX | -0.03% | +1.31% | +14.15% |
07-15 | Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast... | |
07-15 | AstraZeneca: acquisition of Amolyt Pharma finalized | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.15% | 244B | |
+62.80% | 856B | |
+38.95% | 631B | |
-4.15% | 359B | |
+17.51% | 325B | |
+8.62% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.29% | 177B | |
+1.97% | 165B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Who Set To Approve Astrazeneca Covid-19 Vaccine Manufactured By Sk Bioscience In South Korea From End Of Feb - Document